Eiger Australian Small Companies is an Managed Funds investment product that is benchmarked against ASX Index Small Ordinaries Index and sits inside the Domestic Equity - Micro Cap Index. Think of a benchmark as a standard where investment performance can be measured. Typically, market indices like the ASX200 and market-segment stock indexes are used for this purpose. The Eiger Australian Small Companies has Assets Under Management of 21.38 M with a management fee of 1%, a performance fee of 1.20% and a buy/sell spread fee of 0.81%.
The recent investment performance of the investment product shows that the Eiger Australian Small Companies has returned 4.04% in the last month. The previous three years have returned -2.44% annualised and 19.62% each year since inception, which is when the Eiger Australian Small Companies first started.
There are many ways that the risk of an investment product can be measured, and each measurement provides a different insight into the risk present. They can be used on their own or together to perform a risk assessment before investing, but when comparing investments, it is common to compare like for like risk measurements to determine which investment holds the most risk. Since Eiger Australian Small Companies first started, the Sharpe ratio is NA with an annualised volatility of 19.62%. The maximum drawdown of the investment product in the last 12 months is -5.47% and -30.99% since inception. The maximum drawdown is defined as the high-to-low decline of an investment during a particular time period.
Relative performance is what an asset achieves over a period of time compared to similar investments or its peers. Relative return is a measure of the asset's performance compared to the return to the other investment. The Eiger Australian Small Companies has a 12-month excess return when compared to the Domestic Equity - Micro Cap Index of -9.53% and -0.86% since inception.
Alpha is an investing term used to measure an investment's outperformance relative to a market benchmark or peer investment. Alpha describes the excess return generated when compared to peer investment. Eiger Australian Small Companies has produced Alpha over the Domestic Equity - Micro Cap Index of NA% in the last 12 months and NA% since inception.
For a full list of investment products in the Domestic Equity - Micro Cap Index category, you can click here for the Peer Investment Report.
Eiger Australian Small Companies has a correlation coefficient of 0.95 and a beta of 0.82 when compared to the Domestic Equity - Micro Cap Index. Correlation measures how similarly two investments move in relation to one another. This establishes a 'correlation coefficient', which has a value between -1.0 and +1.0. A 100% correlation between two investments means that the correlation coefficient is +1. Beta in investments measures how much the price moves relative to the broader market over a period of time. If the investment moves more than the broader market, it has a beta above 1.0. If it moves less than the broader market, then the beta is less than 1.0. Investments with a high beta tend to carry more risk but have the potential to deliver higher returns.
For a full quantitative report on Eiger Australian Small Companies and its peer investments, you can click here for the Peer Investment Report.
For a full quantitative report on Eiger Australian Small Companies compared to the ASX Index Small Ordinaries Index, you can click here.
To sort and compare the Eiger Australian Small Companies financial metrics, please refer to the table above.
This investment product is in the process of being independently verified by SMSF Mate. Once we have verified the investment product, you will be able to find more information here.
SMSF Mate does not receive commissions or kickbacks from the Eiger Australian Small Companies. All data and commentary for this fund is provided free of charge for our readers general information.
The S&P/ASX Small Ordinaries Index (XSO) decreased by 1.3% during the month. The Small Industrials decreased by 1.5%, while the Small Resources decreased by 0.9%. The XSO finished the month on a 2yr forecast P/E ratio of 17.1x which is 0.3% above its 5-year average. This valuation is a 9.6% premium to the ASX200.
The best performing sectors for the month were Wholesale, Distribution & Manufacturing (+11.7%), Retail (+9.2%), Automotive (+8.4%), and Precious Metals (+7.1%). The worst performing sectors were Biotechnology (-11.1%), Critical Minerals (-9.7%), Industrial Technology (-9.3%), and Base & Industrial Metals (-9.2%).
The best performing stocks within the XSO Index were Audinate (AD8 +48.3%), Deep Yellow (DYL +37.2%), Red 5 (RED +36.1%), and Baby Bunting (BBN +35.2%). Audinate’s FY23 results showed strong revenue growth and good cost control. Deep Yellow benefited from a stronger uranium price. Red 5 reported a strong profit result and Baby Bunting has had a better than expected start to FY24.
The worst performing stocks in the XSO index were Mesoblast (MSB -55.5%), Chalice Mining (CHN -39.6%), IRESS (IRE -38.3%), and Core Lithium (CXO -38.3%). Mesoblast failed again to convince the FDA to approve its first of a kind remestemcel-L biologic. Chalice released their Gonneville scoping study that contained a much higher capex estimate than expected and somewhat optimistic commodity price assumptions. IRESS reported its first operating result post its recent investor day and disappointed on almost every expected metric. Core Lithium continued to disappoint operationally requiring a further capital raise.
The S&P/ASX Small Ordinaries Index (XSO) increased 3.5% during the month. The Small Industrials increased by 4.8%, while the Small Resources increased by 0.1%. The XSO finished the month on a 2yr forecast P/E ratio of 16.8x which is 1.5% below its 5-year average. This valuation is a 7.9% premium to the ASX200.
The best performing sectors for the month were Banks (+12.6%), Retail (+11.3%), Mining Services & Engineering (+11.1%), and Wholesale, Distribution & Manufacturing (+10.9%). The worst performing sectors were Critical Minerals (-10.0%), Healthcare (-0.7%), Infrastructure & Utilities (+0.5%), and Metals & Mining – Steel (+0.8%).
The best performing stocks within the XSO Index were SiteMinder (SDR +44.2%), Megaport (MP1 +41.3%), Kogan. com (KGN +25.4%), and Australian Ethical (AEF +23.2%). SiteMinder reported better than expected 4Q cashflow. Megaport upgraded guidance. Kogan announced preliminary FY23 EBITDA that was ahead of expectations.
The worst performing stocks in the XSO index were Bowen Coking Coal (BCB -31.3%), Core Lithium (CXO -29.0%), Lake Resources (LKE -25.0%), and Syrah Resources (SYR -22.7%). Bowen Coking Coal reported a weaker than expected 4Q net cashflow. Core Lithium and Lake Resources both updated medium term production expectations downward with higher operating costs. Syrah announced that production was paused in May and June.
The S&P/ASX Small Ordinaries Accumulation Index returned -0.5% for the quarter. The fund outperformed the market and returned 2.1% (net) over the same period.
The S&P/ASX Small Ordinaries Index (XSO) was down 0.5% during the quarter. The Small Industrials increased by 2.3%, while the Small Resources declined by 7.5%. The XSO finished the month on a 2yr forecast P/E ratio of 15.9x which is 7.0% below its 5-year average. This valuation is a 6.5% premium to the ASX200.
The best performing sectors for the quarter were Building & Construction Products (+18.9%), Real Estate Management & Development (+16.1%), Biotechnology (+12.8%) and Asset Management (+8.7%). The worst performing sectors were: Metals & Mining – Precious (-13.6%), Wholesale, Distribution & Manufacturing (-13.2%), Banks (-11.9%) and Metals & Mining – Steel (-10.9%).
The best performing stocks within the XSO Index during the quarter were Leo Lithium (LLL +105.8%), Megaport (MP1 +75.2%), Temple & Webster (TPW +70.9%), and Telix Pharma (TLX +62.6%). Leo Lithium announced a $106m strategic placement to battery maker Ganfeng. Megaport is viewed a beneficiary of AI. Temple & Webster announced a better than expected update in early May.
The S&P/ASX Small Ordinaries Accumulation Index returned -3.3% for the month. The fund outperformed the market and returned -0.9% over the same period.
The S&P/ASX Small Ordinaries Index (XSO) declined 3.3% during the month. The Small Industrials declined by 1.7%, while the Small Resources declined by 7.1%. The XSO finished the month on a 2yr forecast P/E ratio of 15.6x which is 8.7% below its 5-year average. This valuation is a 8.1% premium to the ASX200. The best performing sectors for the month were Biotechnology (+4.3%), Industrial Technology (+4.0%), Building & Constr Products (+3.4%), and IT Products & Services (+2.8%). The worst performing sectors were Retail (-13.6%), Base & Industrial Metals (-10.9%), Automotive (-9.8%), and Precious Metals (-2.5%).
The best performing stocks within the XSO Index were Leo Lithium (LLL +69.5%), ADBRI (ABC +36.3%), Life360 (360 +34.1%), and OFX (OFX +28.4%). Leo Lithium received funding from a strategic placement from Ganfeng Lithium. ADBRI disclosed that underlying NPAT for Jan-Apr 2023 was significantly higher than the same period last year. Life360 reported a strong 1Q23 update.
The worst performing stocks in the XSO index were 29metals (29M -40.5%), Vulcan Energy (VUL -38.6%), 5E Advanced Materials (5EA -35.4%), and Accent (AX1 -30.1%). 29metals disclosed higher capex at its Capricorn Copper & Golden Grove mines. Vulcan Energy raised equity at a significant discount. The market was disappointed with 5E Advanced Materials 3Q update.
The S&P/ASX Small Ordinaries Accumulation Index returned 2.8% for the month. The fund outperformed the market and returned 3.2% over the same period.
The S&P/ASX Small Ordinaries Index (XSO) increased 2.8% during the month. The Small Industrials increased by 3.6%, while the Small Resources increased by 0.7%. The XSO finished the month on a 2yr forecast P/E ratio of 15.6x which is 8.5% below its 5-year average. This valuation is a 6.7% premium to the ASX200. The best performing sectors for the month were Biotechnology (+14.8%), Building & Construction Products (+9.8%), Aged Living (+8.0%), and Real Estate Management (+7.9%).
The worst performing sectors were Metals & Mining – Steel (-5.5%), Wholesale, Distribution & Manufacturing (-4.0%), Industrial Technology (-3.2%), and Metals & Mining – Critical Minerals (-2.5%). The best performing stocks within the XSO Index were Telix Pharma (TLX +47.1%), Megaport (MP1 +36.7%), Blackmores (BLK +35.0%), and Codan (CDA +34%). Telix reported a very strong 1Q trading update. Megaport provided higher FY23 earnings guidance while Blackmores was subject to a takeover offer.
The worst performing stocks in the XSO index were Syrah Resources (SYR -37.0%), NOVONIX (NVX -22.1%), 5E Advanced Materials (5EA -18.8%), and Hastings Technology (HAS -17.7%). Syrah reported a weak 1Q production and sales update. Novonix received a 1st negative vote on the remuneration report at the AGM. Novonix, like Syrah is involved in the production of graphite for batteries.
The S&P/ASX Small Ordinaries Accumulation Index returned +1.9% for the quarter. The fund outperformed the market and returned 2.8% (net) over the same period.
The S&P/ASX Small Ordinaries Index (XSO) was up 1.9% during the quarter. The Small Industrials increased by 1.3%, while the Small Resources increased by 2.9%. The XSO finished the month on a 2yr forecast Price-to-Earnings (P/E) ratio of 15.2x which is 10.7% below its 5-year average. This valuation is a 6.4% premium to the ASX200.
The best performing sectors for the quarter were Wholesale, Distribution & Manufacturing (+18.1%), Automotive (+13.0%), Infrastructure & Utilities (+10.9%) and Biotechnology (+9.0%). The worst performing sectors were: Industrial Technology(-17.5%), Aged Living (-10.0%), Agricultural Products (-8.0%), and Real Estate Management and Developers (-6.0%).
The best performing stocks within the XSO Index during the quarter were Liontown Resources (LTR +95.5%), Neuren Pharma (NEU +70.0%), Westgold Resources (WGX +50.0%), and Accent Group (AX1 +49.0%). Liontown received a non binding offer at a substantial premium from US lithium major Albemarle. Neuren Pharma received FDA approval for the sale of DAYBLU, a treatment for Rett Syndrome. Westgold Resources responded to higher gold prices and a positive update from its BIg Bell mine.
The worst performing stocks in the XSO index were Jervois Global (JRV -76.0%), Bravura (BVS -59.9%), Lake Resources (LKE -44.4%), and 29metals (29M -38.0%). Jervois, a prospective cobolt miner, has halted its US project as current cobolt prices are not strong enough to make the project viable. Bravura completed a deeply discounted capital raising while Lake Resources responded to lower lithium prices and a substantial sell down by management.
The S&P/ASX Small Ordinaries Accumulation Index returned 6.6% for the month. The Eiger Australian Small Companies Fund underperformed the market and returned 6.2% over the same period.
The S&P/ASX Small Ordinaries Index (XSO) was up 6.6% during the month. The Small Industrials increased by 6.3%, while the Small Resources increased by 7.3%. The XSO finished the quarter on a 2yr forecast P/E ratio of 18.3x which is 7.1% above its 5-year average. This valuation is a 21.5% premium to the ASX200. The best performing sectors for the month were Retail (+18.7%), Metals & Mining – Critical Minerals (+16.1%), Healthcare (12.0%), and Media (+11.3%). The worst performing sectors were: Automotive (+1.6%), Biotechnology (+1.3%), Agricultural Products (+1.0%), and Telecommunications (-0.5%). The best performing stocks within the XSO Index were Westgold Resources (WGX +38.9%), Sayona Mining (SYA +36.8%), City Chic (CCX 35.8%), and Adairs (ADH +30.9%). Westgold gave an operational update and affirmed guidance. Sayona gained on lithium sector strength. City Chic benefitted from the market’s positive reaction to talk of involvement by investor Brett Blundy. Holiday trading period optimism supported the Adairs share price.
The worst performing stocks in the XSO index were Austal (ASB -20.2%), Betmakers Technology (BET -18.2%), OFX Group (OFX -17.2%), and BrainChip (BRN -15.4%). Austal reduced EBIT guidance by 40% weeks after previous guidance was given. Betmakers restructured it’s board and management, demoting the CEO. OFX provided dissapointing Q3 results, whilst Brainchip issued a capital call with a funding partner before announcing Q4 cashflow.
Product Snapshot
Product Overview
Performance Review
Peer Comparison
Product Details